ASIF420 Cannabis Ventures (“ASIF420” or the “Company”) has completed its first transfer of high quality medical grade cannabis strains from the Company’s cannabis strains suppliers in the UK to it’s cultivation hub in Lesotho, South Africa, as part of the Company’s previously announced Strategic Partnership (the “Partnership”) in the UK. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health UK, an import permit from the Lesotho Medicines Agency and a phytosanitary certificate from the South African Food Inspection Agency.

“We are pleased to introduce the first medical strains to be produced in Africa, through our strategic alliance with EU partners,” said Mr. Tal Arbeli, Managing Director of ASIF420 who is overseeing the Partnership. “This marks another important milestone for ASIF420 as we extend our leadership position in the European market, and it gives me joy to be able to say today that we literally have a good thing growing in Europe.”

As previously announced, ASIF420 will handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets across Europe as medical cannabis markets develop.